| 22:00 - 23:30 | Workshop Session: An Overview of Organ-Specific Transplantation in Children (diagnoses, procedures, outcome) |
|
Discussion and Q&A - -, |
| 202.2 |
Liver Winita Hardikar, Australia |
| 202.1 |
Kidney Katherine Twombley, United States |
| 202.3 |
Thoracic Jonathan Johnson, United States |
| 202.4 |
Pediatric Intestinal Transplantation George V. Mazariegos, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Technique for Minimizing Complication |
| 221.3 |
Bile duct: Achilles heel Kenneth Siu Ho Chok, Hong Kong |
| 221.2 |
Hepatic artery: Micro-world Mureo Kasahara, Japan |
| 221.1 |
Hepatic vein and portal vein: Major in and out Shin Hwang, Korea |
| 00:15 - 02:00 | State-of-the-Art Session: Expanding the Donor Pool, Pushing the Limits |
| 222.2 |
Use of DCD organs in heart and lung transplant Gregory I Snell, Australia |
| 222.1 |
Use of HCV positive organs into HCV negative recipients David Goldberg, United States |
| 222.3 |
Transplant outcomes from older donors > Age 60 Colleen L. Jay, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Inhaling the Evidence (Lung) |
| 223.1 |
Increasing allograft utilization and redefining marginality (to include discussion on Hep C, ischaemic time and Ex-situ perfusion) Alejandro Mario Bertolotti, Argentina |
| 223.3 |
Survivorship in lung transplantation (there is a constant need to reinforce that the surgical component alone is only a small step in the transplant process) Hilary J. Goldberg, United States |
| 07:30 - 08:15 | Oral Abstracts Session: Clinical Trials in Pediatric Transplantation |
| 252.2 |
Steering of transplant immunosuppression by virus-specific T cells: A randomized controlled trial (IVIST trial) Thurid Ahlenstiel-Grunow, Germany |
| 252.4 |
Prospective non-randomized open label trial comparing outcome of open versus robotic pediatric kidney transplant at single centre Dhruv B Patel, India |
| 08:15 - 10:00 | State-of-the-Art Session: Evidence-Based Teaching |
| 260.1 |
Cognitive sciences based design of engaging training programs for transplant professionals Margaret Hay, Australia |
| 260.2 |
Ethical principles for transplant professionals: How do we teach that? Dominique Martin, Australia |
| 260.3 |
Future transplant surgeons: How do we train them? Abul Siddiky, United Kingdom |
| 08:15 - 10:00 | State-of-the-Art Session: Banff 2019 Update for Allograft Rejection |
| 262.1 |
Liver (morphology) Andrew Clouston, Australia |
| 262.4 |
Kidney (molecular) Carmen Lefaucheur, France |
| 262.3 |
Kidney (morphology) Hyeon Joo Jeong, Korea |
| 262.2 |
Liver (molecular phenotyping) Alberto Sanchez-Fueyo, United Kingdom |
| 13:00 - 14:30 | Workshop Session: Specific Challenges in Pediatric Transplantation |
| 277.1 |
Research in paediatric transplantation Stephen Alexander, Australia |
|
Dr. Alexander Q&A discussion (4 minutes) - -, |
| 277.2 |
Transition Lars Pape, Germany |
| 277.3 |
Adherence Bethany J. Foster, Canada |
| 277.4 |
Steroids and growth Ryszard Grenda, Poland |
| 14:30 - 15:15 | Oral Abstracts Session: Biomarkers and Omics |
| 281.3 |
Single cell transcriptomic analysis for a better understanding of human CD8+ regulatory T cells Céline Serazin, France |
| 281.1 |
Transplantation of older organs transfers senescence Jasper Iske, Germany |
| 281.5 (P-2.125 in Journal) |
TCR repertoire sequencing of total T cells and circulating follicular helper T cells in kidney transplant recipients Patricia Almendro Vázquez, Spain |
| 281.2 |
Diagnosis of kidney transplant rejection by tracking donor-reactive T-cell clones in the post-transplant biopsy, blood and urine samples Joseph R. Leventhal, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Kidney Transplantation: The borg and beyond |
| 290.1 |
The repair shop: Our current opportunities in improving the quality of kidneys Sarah Hosgood, United Kingdom |
| 290.2 |
A reality check - kidney organoids: What to expect in the next 10 years Benjamin Humphreys, United States |
| 290.3 |
Artificial intelligence in renal transplantation: core concepts, examples, limits and perspectives Olivier Niel, Luxembourg |
| 15:15 - 17:00 | State-of-the-Art Session: Social Media for Scientists |
| 291.3 |
Impact of social media on research dissemination Carla C. Baan, Netherlands |
| 291.1 |
Introduction and creating networks Frank JMF Dor, United Kingdom |
| 291.2 |
Healthcare and patient education Macey L. Henderson, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Donation in Middle Income Countries: Challenges to be overcome in the next 5 years |
| 292.1 |
What is the current involvement and support from the governments in the different TTS regions and what needs to changed in order to reach self-sufficiency? Curie Ahn C Ahn, Korea |
| 292.2 |
Role of intensivists / ICU specialists, how to have them more involved? Rafael Badenes, Spain |
| 292.3 |
Successful models of DOD in developing countries Katayoun Najafizadeh, Iran (Islamic Republic of) |
| 23:30 - 00:15 | Oral Abstracts Session: Experimental and Preclinical Immunosuppression |
| 312.2 |
Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection Christina Lai, Australia |
| 312.4 |
ABO self-tolerance in a mouse model: Evidence of tolerance at B cell but not T cell level Ibrahim Adam, Canada |
| 312.3 |
Carfilzomib and lulizumab-based desensitization prolongs allograft survival in sensitized non-human primates kidney transplantation model Jean Kwun, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Advances in Liver and Intestinal Transplantation in Children |
| 313.2 |
Ionizing radiation exposure review in children with intestinal failure Ana c Grasso, Argentina |
| 313.4 |
Significance of sarcopenia in infants with pediatric liver transplantation for biliary atresia Masahiro Takeda, Japan |
| 313.1 |
Should steatotic livers be transplanted into pediatric recipients? Malcolm MacConmara, United States |
| 313.3 |
Marginal livers have excellent outcomes in pediatric patients with metabolic liver disease Christine Hwang, United States |
| 06:00 - 07:30 | Workshop Session: TTS-ELPAT Joint Workshop on Cutting Edge in Transplant Ethics |
| 342.2 |
Overcoming the Challenge of Finding a Living Donor Emma K. Massey, Netherlands |
| 342.4 |
Organ recycling: is this the future? David M. Shaw, Switzerland |
| 342.1 |
Should we abandon the term brain death? Dale Gardiner, United Kingdom |
| 342.3 |
Extremes in living organ donation Frank JMF Dor, United Kingdom |
| 07:30 - 08:15 | Oral Abstracts Session: Deceased Organ Donation |
| 352.3 |
Settling the difference: Analysis of kidney graft function discordance at transplant from deceased donor paired kidneys Essa Abuhelaiqa, Qatar |
| 08:15 - 10:00 | State-of-the-Art Session: The Future is Now… Immune Regulation in Transplantation |
| 360.1 |
The Regulation of Immune Tolerance by FOXP3 - basic Ling Lu, People's Republic of China |
| 360.2 |
Intragraft immune regulation protects transplants under sub-therapeutic immunosuppression Paloma Riquelme, Germany |
| James Alexander Hutchinson, Germany |
| 360.3 |
Clinical experience of Treg therapy Fadi Issa, United Kingdom |
| 13:00 - 14:45 | Workshop Session: Global Strategies for Facilitating Ethical Practices in Organ Transplantation |
| 377.4 |
Developing programs in resource constrained areas – Vietnam Richard Allen, Australia |
| 377.3 |
Organ transplantation for refugees: The Latin American case Alejandro Niño Murcia, Colombia |
| 377.5 |
Combating paid donation in India Vivek Kute, India |
| 377.8 |
Strategies for increasing deceased donation in Iran Seyed Ali Malek Hosseini, Iran (Islamic Republic of) |
| 377.6 |
Combating paid donation in the Philippines Benita Padilla, Philippines |
| 377.1 |
Resident minorities Access to organ donation and transplantation – Middle-East Riadh Fadhil, Qatar |
| 377.2 |
Non-resident access to transplantation and impact on local lists – Europe Beatriz Domínguez-Gil, Spain |
| 377.7 |
Transplanting the undocumented in the USA Peter G. Stock, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Graft allocation and Other Key Topics in Pediatric Kidney Transplantation |
| 382.3 |
Association of graft survival with tacrolimus exposure and late intra-patient tacrolimus variability in pediatric and young adult renal transplant recipients Caner Suesal, Germany |
| 382.1 |
Access to kidney transplantation for minority children with end-stage renal disease and predictors of outcomes (presented by Robyn Matloff) Robyn Matloff, United States |
| 382.4 |
Pulsatile perfusion in pediatric kidney transplantation Christine Hwang, United States |
| 15:15 - 17:00 | State-of-the-Art Session: How to Deal with Hepatocellular Carcinoma |
| 390.3 |
Post-LT: optimal immunosuppression and follow-up Nancy Kwan Man, Hong Kong |
| 390.1 |
Pre-LT: down-staging and optimal selection Kim M. Olthoff, United States |
| 390.2 |
Intra-LT: how to improve oncologic outcomes Elizabeth A. Pomfret, United States |
| 390.4 |
Liver Tx for cholangiocarcinoma Julie K. Heimbach, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Novel Insights in Allorecognition |
| 391.2 |
T-cell allorecognition Gavin Pettigrew, United Kingdom |
| 391.3 |
Non-HLA allorecognition and graft loss Roman Reindl-Schwaighofer, Austria |
| 391.1 |
Innate allorecognition Fadi G. Lakkis, United States |
| 15:15 - 17:00 | State-of-the-Art Session: How Sex Impacts Post-Transplant Course |
| 392.2 |
Sex differences in infection risks and vaccine responses Deepali Kumar, Canada |
| 392.1 |
Sex differences in cancer risk post-transplant Anna Buxeda, Spain |
| 392.3 |
Sex and the heart: Major cardiovascular events in transplantation Darshana Dadhania, United States |
| 22:00 - 23:30 | Workshop Session: TTS-ISHLT Joint Symposium: Capacity Building in Transplantation: Meeting Challenges Through Global Partnership |
| 402.3 |
Establishing ethical and legal standards – From organ trade to presumed consent Wendy Rogers, Australia |
| 402.2 |
DCD in heart and lung transplantation – Is there a need for a global standard? Kumud K Dhital, India |
| 402.4 |
Emerging programs - Dealing with the challenges of a global pandemic Saima Aslam, United States |
| 402.1 |
Collaborative models of organ allocation in an era of populism Howard J. Eisen, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Living Organ Donation |
| 411.3 |
When length becomes less: Minimum renal artery length required in left laparoscopic live donor nephrectomy Anant Kumar, India |
| 411.1 |
Impact of extended living donor criteria on donor safety in living donor liver transplantation Joo Dong Kim, Korea |
| 411.2 |
Evolution of right laparoscopic nephrectomy: Report of a tertiary care center in Mexico LORENA NORIEGA-SALAS, Mexico |
| 411.4 |
Determination of type 2 diabetes mellitus risk in potential living kidney donors: A single center protocol and experience Golnaz G Friedman, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Preventable Infections - An Ounce of Prevention... |
| 420.2 |
Screening and decolonization of MDROs pre-transplant: Is there a role? Stephanie Pouch, United States |
| 420.1 |
Respiratory viruses - Impact on our recipients Michael G. Ison, United States |
| 420.3 |
Keeping the fungi out of the transplant ward Monica Slavin, Australia |
| 06:00 - 07:30 | Workshop Session: Global Ethical Issues |
| 441.2 |
Organ donation after euthanasia Diethard Monbaliu, Belgium |
| 441.3 |
Ethical issues in xenotransplantation and stem cell trials Ian D. Dittmer, New Zealand |
| 441.4 |
Ethical issues involved with informed consent for living donors Guia Crisostomo-Tan, Philippines |
| 441.1 |
Ethics and the social network in transplantation Elmi Muller, South Africa |
| 06:00 - 07:30 | Workshop Session: Unique Aspects of Organ Donation and Assessment in Pediatric Transplantation |
| 442.1 |
Risks for the living donor Michael Kaabak, Russian Federation |
| 442.2 |
Culture and religious perspectives Jun Oh, Germany |
| 442.4 |
ABO- and HLA- Incompatible transplantation Seiichiro Shishido, Japan |
| 442.3 |
Challenges of small paediatric donors Nam-Joon Yi, Korea |
| 08:15 - 10:00 | State-of-the-Art Session: A Kidney for Life: A goal for all practitioners |
| 460.1 |
A look at the long-term surviving patient: What makes them so exceptional? Germaine Wong, Australia |
| 460.2 |
Chronic allograft injury: CAN CAN be fixed? Dirk R. J. Kuypers, Belgium |
| 460.3 |
Anti-body mediated rejection: Consensus on treatment? Roslyn B Mannon, United States |
| 13:00 - 14:30 | Workshop Session: CMV - What's New |
| 477.3 |
New risks for CMV in solid organ and stem cell transplant recipients José Maria Aguado, Spain |
| 477.1 |
New drugs against an old foe Francisco M Marty, United States |
| 477.2 |
Immune monitoring Camille Nelson Kotton, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Education Abstract Session |
| 482.4 |
The efficiency of educational courses for increasing organ donation rates; The IrOSS experience
Marzieh Latifi, Iran (Islamic Republic of) |
| 482.1 |
Analysis of the effects of coordinator mental health management program Kyungsook Jang, Korea |
| 482.2 |
i-DTI: An electronic consultancy platform between professionals in the field of organ donation and transplantation Estephan Arredondo, Spain |
| 482.3 |
Save lives! Say yes! Increasing donor designation rates through targeted, demographic specific public education: Turning opportunity into outcomes Betsy Edwards, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Paediatric Transplantation Around the World |
| 491.1 |
Paediatric kidney transplantation around the world Mignon McCulloch, South Africa |
| 491.2 |
Cost Effective Immunosuppressive Medications Around the World Katherine Twombley, United States |
| 491.3 |
Variety of vaccine preventive paediatric infectious diseases around the world Lara Danziger-Isakov, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Declaration of Istanbul Issues |
| 493.1 |
Global organ trafficking registry Patrick Coates, Australia |
| 493.2 |
What is wrong with de Global Kidney Exchange Program Alexander M. Capron, United States |
| 493.3 |
The MAIN obstacle to increase organ transplantation in Africa Elmi Muller, South Africa |
| 493.4 |
The MAIN obstacle to increase organ transplantation in the Middle-East Refaat Kamel, Egypt |
| 493.5 |
The MAIN obstacle to increase organ transplantation in Latin America Maria A. Matamoros, Costa Rica |
| 493.6 |
The MAIN obstacle to increase organ transplantation in Asia Sanjay Nagral, India |
| 493.7 |
The MAIN obstacle to increase organ transplantation in Europe Axel Rahmel, Germany |
| 493.8 |
Final Remarks and Panel Discussions Alejandro Niño Murcia, Colombia |
| Poster Session: Education |
| P-5.11 |
Influence of promotional strategies for the donation and transplantation of organs, fabrics and cells in the petroleum hospital of Bolivia, 2020 Tatiana Rosario Cruz Jr., Bolivia |
| P-5.08 |
Effectiveness of a structured sub-maximal stress test for screening asymptomatic post-organ transplant recipients before safe return to sports competition Ka-Foon Chau, Hong Kong |
| P-5.12 |
Measuring the relationship between subjective health literacy and access to kidney transplantation among chronic renal patients in Eastern Hungary Anita Barth, Hungary |
| P-5.14 |
Knowledge and attitude towards organ donation and transplantation among a sample of Iraqis in the city of Baghdad Ala Ali, Iraq |
| P-5.03 |
TPM training program in tissue banking & advanced therapies: A 15-year experience Chloë Ballesté, Spain |
| P-5.04 |
Survey on leadership, management, quality and innovation in organ procurement for the self-sufficiency in organ donation of the one belt & one road area Marti Manyalich Vidal, Spain |
| P-5.07 |
KeTLOD Bridge : Scholarships for facilitating the transfer of knowledge and leadership in organ donation and transplantation from Europe to China (2018-2019) Chloë Ballesté, Spain |
| P-5.15 |
Dance as a medium to educate and make comprehensible the biology of allotransplant rejection Pranitha Kamat, Switzerland |
| P-5.06 |
Transformative learning in pharmacy education: A paradigm shift for training transplant pharmacists Sayamon Sukkha, Thailand |
| P-5.01 |
Eliminating patient controlled analgesia reduces opioid use in renal transplant recipients Marisa E Schwab, United States |
| Poster Session: Paediatrics |
| P-13.06 |
1 -year protocol biopsies in pediatric kidney transplant children: Are unfavorable histological lesions related to no adherence? Marta Lidia Monteverde, Argentina |
| P-13.10 |
Addition of pre transplant Rituximab to plasma exchange in FSGS children undergoing kidney transplantation Marta Lidia Monteverde, Argentina |
| P-13.24 |
Paediatric Lung Transplantation (pLTx) in Australia: Small patients in a big country Belinda J Bourne, Australia |
| P-13.23 |
Successful preemptive kidney transplantation with simultaneous bilateral nephrectomy in young infants with congenital nephrotic syndrome Lan Zhu, People's Republic of China |
| P-13.18 |
CT based sarcopenia assessment & frailty scores are better than PELD in predicting early morbidity and mortality after paediatric live donor liver transplantation Sugi R V Subramaniam, India |
| P-13.07 |
Comprehensive analysis of 40-year experience in pediatric kidney transplantation Chris T Chung, Korea |
| P-13.19 |
Kidney transplantation in children weighing 15 kg or less: Technical challenges and outcome in a single center Okjoo Lee, Korea |
| P-13.21 |
Long-term survival of kidney transplants in pediatric patients with nephronophthisis Jiyoung Kim, Korea |
| P-13.29 |
Clinical course of Schimke immuno-osseous dysplasia after kidney transplantation Hyun Ah Woo, Korea |
| P-13.13 |
ABO-incompatible pediatric liver transplantation: Experience of 122 procedures at a single center Irina E. Pashkova, Russian Federation |
| P-13.22 |
Blood levels of insulin like growth factor-1 (IGF-1) and growth hormone associate with liver function and 6 month survival after pediatric liver transplantation Rivada Kurabekova, Russian Federation |
| P-13.16 |
The effects of long term eplerenone treatment in pediatric renal transplant patients Esra Baskin, Turkey |
| P-13.17 |
Risk factors and outcomes of urinary tract infections after pediatric renal transplant Esra Baskin, Turkey |
| P-13.20 |
Outcomes of renal transplantation in children with cystinosis Esra Baskin, Turkey |
| P-13.25 |
Clinical impact of complement deposition findings on biopsies in acute rejection episodes of pediatric renal transplant patients Esra Baskin, Turkey |
| P-13.30 |
Succesfully kidney transplantation in pediatric patient with inferior vena cava stent Behlul Igus, Turkey |
| P-13.14 |
Extracorporeal photopheresis: Treatment for steroid resistant rejection in pediatric liver transplant recipients Julie Depper, United States |
| P-13.28 |
The growth and impact of pediatric donation in the United States Thomas Nakagawa, United States |
